Nature of Operation:
 
 Siemens Healthcare Diagnostics Limited (the Company), a public
 limited company registered under the Companies Act, 1956 engaged in
 manufacturing, marketing and customer support of Medical Diagnostic
 Reagents and Instrument.
 
                                     As at            As at
                               30 September,      30 September,
                                     2010              2009
 
 2 Contingent liabilities
 
 Taxation matters
 
 In respect of certain completed 
 assessments where matters are 
 under appeal by the Company        10,686            24,714
 
 Excise liabilities under dispute   22,540            22,529
 
 Sales tax liabilities under 
 dispute                            10,471            15,970
 
 Pending C Form Liabilities            196               745
 
 Matter in respect of which there 
 is appeal before Service Tax 
 Authorities (excluding interest 
 and penalty thereon which is 
 unascertainable).                   2,192             2,192
 
 Demand of Customs authorities for 
 interest on differential
 duty on final assessment              206               206
 
 Penalty for non fulfillment of 
 export obligation                     500               500
 Claims against the Company not 
 acknowledged as debts               1,877             1,877
 
 3 Disclosure relating to Provisions for Warranty
 
 Warranty provision covers the expenses related to the repairing and
 maintenance of equipment sold which are generally covered by yearly
 warranty. The amount is determined on the basis of experience of the
 average expenses incurred. Future cash flow in respect of the same is
 expected to occur over the period of the warranty. Unutilised balances,
 if any are written back on expiry of commitment.
 
 4 Related party transactions
 
 4.1 Parties where control exists
 
 Siemens AG, Germany Ulitimate holding company
 
 Siemens Diagnostics Holding II B.V., Netherlands Holding company (holds
 68.73% of the Equity shares of the Company as at year end)
 
 4.2 Other related parties where transactions have taken place during
 the year Fellow Subsidiaries
 
 Siemens Healthcare Diagnostics Inc, USA
 
 Siemens Healthcare Diagnostics Manufacturing Ltd., George Town, Cayman
 Islands
 
 Siemens Healthcare Diagnostics Manufacturing Ltd., Sudbury, U.K.
 
 Siemens Healthcare Diagnostics Products Ltd., Lianberies, U.K.
 
 Siemens Medical Solutions Diagnostics Europe Limited
 
 Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany
 
 Siemens Healthcare Diagnostics S.A., Belgium
 
 Siemens Healthcare Diagnostics Ltd., Hongkong
 
 Siemens Healthcare Diagnostics Pte Ltd., Singapore
 
 Siemens Pte Ltd, Singapore
 
 Siemens Ltd. Bayswater, Australia
 
 Dade Behring Diagnostics AG, Duedingen, Switzerland
 
 Siemens Limited, India
 
 Siemens Information System Limited, India
 
 Siemens Inoformation Processing Services Pvt. Ltd., India
 
 Siemens Corporate Finance Private Limited, India
 
 Siemens Healthcare Diagnostics,Shanghai, China
 
 Siemens Healthcare Diagnostics Manufacturing Ltd., Ireland
 
 Key Managerial Personnel
 
 P Siva Kumar (till 30.11.2009) Managing Director
 
 Anil Shankar Whole-time Director and CFO
 
 5 Segment Reporting
 
 The Company is in the business of manufacturing, trading and dealing in
 various diagnostic products, which have similar risk and returns and
 also similar market conditions of demand and supply. The segment
 reporting based on geographical risk factor which may be present in
 different countries is also not applicable, as the Com- pany has
 substantial sales in the domestic market. Thus, there is only one
 identified reportable segment that is Diagnostics.
 
 6 Disclosure pursuant to Accounting Standard -15 (Revised) Employee
 Benefits Defined benefit plan and iong term employment benefit a
 General description Gratuity (Defined benefit plan)
 
 The Company has a defined benefit gratuity plan. Every employee who has
 completed five years or more of service gets a gratuity on death or
 resignation or retirement at 15 days salary (last drawn salary) for
 each completed year of service. The scheme is funded with an insurance
 company in the form of a qualifying insurance policy
 
 Leave wages (Long term employment benefit)
 
 The leave wages are payable to all eligible employees at the rate of
 daily salary for each day of accumulated leave on death or on
 resignation or upon retirement on attaining superannuation age.
 
 The following tables summaries the components of net benefit expenses
 recognised in the profit and loss account and the funded status and
 amounts recognised in the balance sheet for the respective plan.
 
 k Long term employee benefits
 
 The liability towards compensated absences for the year ended September
 30, 2010, based on the actuarial valuation carried out using the
 projected unit credit method amounting to Rs. 5,682 thousands (2009:
 3,130 thousands) has been recognised in the profit and loss account.
 
 1 Other Note
 
 Estimates of future salary increases, considered in actuarial
 valuation, take account of inflation, seniority, promotion and relevant
 factors, such as supply and demand in the employment market.
 
 The overall expected rate of return on assets is determined based on
 the market prices prevailing on that date, applicable to the period
 over which the obligation is to be settled.
 
 The discount rates used for determining the present value of the
 obligation under defined benefit plan, is based on the market yields on
 Government securities as at the balance sheet date.
 
 7 The amount of excise duty disclosed as a deduction from turnover is
 the total excise duty for the period / year except the excise duty
 related to the difference between the closing stock and opening stock
 and excise duty paid but not recovered, which has been disclosed as
 excise duty expense in the Schedule 15.
 
 8 Severance costs
 
 During the year ended September 30, 2008, pursuant to the business
 acquisition of Dade Behring, the Company had decided to shift its
 business operations from Vadodara to New Delhi. Accordingly, the Senior
 Management of the Company had approved and communicated to employees a
 Scheme of Severance Pay (the Scheme) for the employees of the
 Company, including the method of calculating the severance pay, with
 effect from 24 July 2008.  All the employees who have not been offered
 a position in the newly integrated organization in New Delhi or who do
 not wish to relocate themselves to New Delhi or such other place as
 required by the Company are entitled to severance pay under the Scheme.
 Accordingly, the Company had estimated Rs 31,720 thousands towards
 sever- ance pay for 81 identified employees. As on September 30, 2010
 unutilised carrying balance of Severance Pay is Rs. 23,639 thousands
 for remaining 35 employees out of 81 identified employees during
 previous year.
 
 9 The Company has received a letter dated October 11, 2006 from Town
 Planning Officer, Vadodara Urban Develop- ment Authority (VUDA) for
 compulsory acquisition of the Companys land admeasuring 16,995 Sq Mt
 out of total 60,703 Sq Mt. The cost of the total land (60,703 Sq Mt.)
 aggregates to Rs. 486,496. The Company has not received intimation from
 VUDA with regard to the compensation or development charges, if any, in
 lieu of the compulsory acquisition of land.
 
 10 Operating lease
 
 Office premises are obtained on operating lease. The lease term is for
 3 years and renewable for further 3 years at the option of the Company.
 There is no escalation clause in the lease agreement. There are no
 restrictions imposed by lease arrangements. There are no subleases.
 
 Charge to the profit & loss account Rs. 18,255 (2009 Rs. 18,536) Rent
 payable for not more than 1 year Rs 15,570 (2009 Rs. 14,116) more than
 1 year not later than 5 years Rs 649 (2009 Rs. 15,125) more than 5
 years Rs Nil (2009 Rs. Nil)
 
 11 Details of dues to Micro and Small Enterprises as per MSMED Act,
 2006
 
 On the basis of the information and records available with the
 Management, there are no outstanding dues to the Micro and Small
 enterprises as defined in the Micro and Small Enterprises Development
 Act, 2006.
 
 12 Deferred Income
 
 Deferred Income refers to Service Contracts Revenue to be recognised
 over the period of the service contract.
 
 13 The Board of Directors approved the amalgamation of Siemens
 Healthcare Diagnostics Ltd. (SHDL) with Siemens Ltd. on 30 November
 2009. The amalgamation scheme was filed with the Honorable High Courts
 of Gujarat and Bombay and accordingly the Court convened meeting was
 held on 28 January 2010. In terms of the scheme, the appointed date is
 1 October 2009 and the share swap ratio will be two equity shares of
 the face value of Rs. 21- each fully paid up of Siemens Ltd. for one
 equity share of the face value of Rs. 10/- each fully paid up of SHDL.
 Pending approval of the aforesaid High Courts, no effect of the
 proposed amalgamation has been recognised in these financial
 statements.
 
 14 Previous years comparatives
 
 Previous periods figures have been regrouped / reclassified wherever
 necessary, to conform to current years classification.